膀胱癌新辅助化疗后至根治性膀胱切除术的最佳时机探讨
该研究回顾1995-2013年接受新辅助化疗(NAC)后根治性膀胱切除术(RC)的≤cT4 N0 M0膀胱癌患者306例,按NAC结束至RC间隔(RW)以21天分层。结果显示RW 18-84天各组围手术期并发症无差异,而RW≥85天者淋巴结阳性率最高(40%),且为淋巴结转移的独立预测因素(OR 2.92,95%CI 1.20-7.09,P=0.018)。
要点
- NAC后18-84天(2.5-12周)行RC不增加围手术期并发症风险。
- RW≥85天者淋巴结阳性率最高(40%),且为淋巴结转移独立预测因素。
- 手术时间≥7小时是主要并发症和再入院的独立预测因素。
核心结论
- NAC后18-84天行RC围手术期并发症风险无差异,延迟超过12周与淋巴结转移风险显著相关。
研究设计与样本
- 回顾性队列研究,纳入1995-2013年接受NAC后RC的≤cT4 N0 M0膀胱癌患者306例,按NAC结束至RC间隔以21天分为四组(18-42、43-63、64-84、≥85天)。
主要发现
- 四组间总体并发症、再入院和主要并发症率无差异。
- multivariable分析中,膀胱外病变是总体并发症的独立预测因素(OR 1.95,95%CI 1.16-3.26,P=0.011)。
- 年龄(OR 1.05,95%CI 1.02-1.09,P=0.004)和手术时间≥7小时(OR 2.87,95%CI 1.52-5.42,P=0.001)是主要并发症的独立预测因素。
- 手术时间≥7小时是再入院的预测因素(OR 2.24,95%CI 1.26-3.98,P=0.006)。
- RW≥85天组淋巴结阳性率最高(40%),且为淋巴结转移的独立预测因素(OR 2.92,95%CI 1.20-7.09,P=0.018)。
临床怎么用
- 膀胱癌NAC后可在18-84天(2.5-12周)内行RC,不增加围手术期并发症风险。
- 应避免将RC延迟至NAC后超过12周,以降低淋巴结转移风险。
局限性
- 回顾性研究,样本量306例,可能存在选择偏倚。
- 未报告其他潜在混杂因素的具体信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether the recovery window (RW) between neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) affects 90-day postoperative morbidity and incidence of lymph node metastasis. PATIENTS AND METHODS: We reviewed patients treated with NAC and RC from 1995 to 2013 for ≤cT4 N0 M0 bladder cancer. The association of the RW with 90-day perioperative morbidity and lymph node metastasis was determined. Generalised linear models were used to determine predictors of each endpoint. Patients were stratified into four RWs by 21-day intervals (18-42; 43-63; 64-84; and ≥85 days) from last day of NAC to RC. RESULTS: We evaluated 306 patients with RW information during the study period. The median (range) RW was 46 (18-199) days. There was no difference in overall morbidity, re-admission, or major complication rates amongst the four RWs. In the multivariable analysis extravesical disease was an independent predictor of overall morbidity (odds ratio [OR] 1.95, 95% confidence interval [CI] 1.16-3.26; P = 0.011). Age (OR 1.05, 95% CI: 1.02-1.09; P = 0.004), and surgical duration ≥7 h (OR 2.87, 95% CI: 1.52-5.42; P = 0.001) were independent predictors of major complications. Only surgical duration ≥7 h was a predictor of re-admission (OR 2.24; 95% CI: 1.26-3.98; P = 0.006). A RW of ≥85 days had the highest incidence of node-positive disease (pN+; 40%). In a separate multivariable model that included clinical predictors for pN+, a RW of ≥85 days was an independent predictor of nodal metastasis (OR 2.92, 95% CI: 1.20-7.09; P = 0.018). CONCLUSION: Patients treated with NAC for bladder cancer can undergo RC between 18 and 84 days (2.5-12 weeks) after NAC with no difference in the risk of perioperative morbidity. Delaying surgery beyond 12 weeks was associated with a significant risk of lymph node metastasis.
引用
- Mmeje CO, Benson CR, Nogueras-González GM, et al. Determining the optimal time for radical cystectomy after neoadjuvant chemotherapy. BJU Int. 2018. PMID: 29569824. doi:10.1111/bju.14211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。